Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 7711 AL 7725

The effects of Lithium on Beta-amyloid deposition and tau phosphorylation: A systematic review

Xiao K, Sayed H, Xing J, Zhang XY, Ai J, Kirichek E, Le GH, Wong S, Valentino K, Teopiz KM, Vinberg M, Rosenblat JD, Lo HKY, Zhang MC, McIntyre RS.

J Affect Disord. 2026 Feb 15;395(Pt A):120721. doi: 10.1016/j.jad.2025.120721. Epub 2025 Nov 17.

Acoustic Stimulation to Improve Slow-Wave Sleep in Alzheimer's Disease: A Multiple Night At-Home Intervention

Van den Bulcke L, Davidoff H, Heremans E, Potts Y, Vansteelandt K, De Vos M, Christiaens D, Emsell L, Jacobson LH, Hoyer D, Buyse B, Vandenbulcke M, Testelmans D, Van Den Bossche M.

Am J Geriatr Psychiatry. 2025 Jan;33(1):73-84. doi: 10.1016/j.jagp.2024.07.002. Epub 2024 Jul 8.

Efficacy of probiotic supplementation in influencing cognitive function in Alzheimer's disease: A systematic review and meta-analysis

Liu W, Guo J, Dong Y, Li J, Wang Y.

J Food Sci. 2025 Jul;90(7):e70037. doi: 10.1111/1750-3841.70037.

Efficacy of AD04, an aluminum-based vaccine adjuvant, in patients with early Alzheimer's disease: Post hoc analysis of AFF006 (NCT01117818), a proof-of-concept, phase 2 randomized controlled trial

Haaland B, Dickson SP, Santana AF, Tanzi RE, Dubois B, Peters O, Grimmer T, Christensen J, Mallinckrodt C, Schneeberger A, Hendrix SB.

J Alzheimers Dis. 2025 Nov;108(1):234-242. doi: 10.1177/13872877251375985. Epub 2025 Sep 15.

Synthetic control methods for n-of-1 and parallel-group trials in Alzheimer's disease: A proof-of-concept study using the I-CONECT

Wu CY, Chen L, Dickson JR, Zhang B, Arnold SE, Dodge HH.

Alzheimers Dement. 2025 Jul;21(7):e70460. doi: 10.1002/alz.70460.

Cognitive behavioural treatment for mild Alzheimer's patients and their caregivers (CBTAC): results of a randomised controlled trial

Forstmeier S, Maercker A, Bohli L, Savaskan E, Roth T.

Aging Ment Health. 2025 Feb;29(2):359-368. doi: 10.1080/13607863.2024.2393748. Epub 2024 Aug 20.

Safety, tolerability, pharmacokinetic and pharmacodynamic effects of the muscarinic M(1) positive allosteric modulator VU0467319 for Alzheimer's disease: a single ascending-dose study in healthy participants

Conley AC, Key AP, Blackford JU, Russell JK, Albert KM, Gong X, Bubser M, Rook JM, Conn PJ, Lindsley CW, Jones CK, Newhouse PA.

Alzheimers Res Ther. 2025 Jul 1;17(1):144. doi: 10.1186/s13195-025-01798-4.

Translational computerized clinical decision support systems for Alzheimer's disease: A systematic review

Lu P, Chen M, Chen L, Lin F, Yang H, Wang Y, Ding X.

J Alzheimers Dis. 2025 Jul;106(2):443-483. doi: 10.1177/13872877251343241. Epub 2025 Jul 1.

Multicomponent exercise interventions for older adults with Alzheimer's disease: A systematic review and meta-analytical perspective

Yang D, Hou N, Jia M.

J Alzheimers Dis. 2025 Aug;106(3):876-889. doi: 10.1177/13872877251346989. Epub 2025 Jun 2.

Effect of antidiabetic drugs in Alzheimer´s disease: a systematic review of preclinical and clinical studies

Corraliza-Gomez M, Vargas-Soria M, Garcia-Alloza M.

Mol Neurodegener. 2025 Oct 27;20(1):112. doi: 10.1186/s13024-025-00894-1.

Effect of the probiotic Escherichia coli Nissle 1917 on serum levels of NADPH oxidase-2 and lipopolysaccharide in patients with Alzheimer's disease

Loffredo L, Alfano AR, Ettorre E, Desideri G, Carnevale R, Forte M, Maglione V, Bartimoccia S, Castellani V, Totè CM, Pignatelli P, Violi F; Neurodegenerative Disease study group.

J Alzheimers Dis. 2025 Jul;106(2):774-782. doi: 10.1177/13872877251345157. Epub 2025 Jul 1.

Efficacy and Safety of Bilateral Deep Brain Stimulation (DBS) for Severe Alzheimer's Disease: A Comparative Analysis of Fornix Versus Basal Ganglia of Meynert

Xu J, Liu B, Shang G, Feng Z, Yang H, Chen Y, Yu X, Mao Z.

CNS Neurosci Ther. 2025 Apr;31(4):e70285. doi: 10.1111/cns.70285.

Patient-Related Barriers to Digital Technology Adoption in Alzheimer Disease: Systematic Review

Panzavolta A, Arighi A, Guido E, Lavorgna L, Di Lorenzo F, Dodich A, Cerami C.

JMIR Aging. 2025 Apr 10;8:e64324. doi: 10.2196/64324.

Safety and immunogenicity of two Tau-targeting active immunotherapies, ACI-35.030 and JACI-35.054, in participants with early Alzheimer's disease: a phase 1b/2a, multicentre, double-blind, randomised, placebo-controlled study

Sol O, Mermoud J, Hallikainen M, Kurl S, Rinne J, Dautzenberg P, Vijverberg EGB, Mummery C, Börjesson-Hanson A, Jonsson M, Ritchie C, Pennington C, Vukicevic M, Gollwitzer E, Fiorini E, Hickman DT, Hliva V, Gray J, Gerasymchuk V, Wagg J, Fournier N, Lê B, Kezic I, Steukers L, Triana-Baltzer G, Theunis C, Streffer J, Kosco-Vilbois M, Pfeifer A, Scheltens P.

EBioMedicine. 2025 Oct;120:105940. doi: 10.1016/j.ebiom.2025.105940. Epub 2025 Sep 18.

Strain specific effects of probiotic supplementation on serum amino acid profiles in Alzheimer's disease: a randomized, double blind, placebo controlled trial

Jouni N, Akhgarjand C, Vahabi Z, Shab-Bidar S, Khalifeh H, Djafarian K.

Sci Rep. 2025 Aug 15;15(1):29924. doi: 10.1038/s41598-025-15355-4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias